<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M570</article-id>
      <article-id pub-id-type="publisher-id">molbank-2008-M570</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>7-Hydroxy-8-acetylcoumarin <italic>N</italic>-Phenylsulfonylhydrazone </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kotali</surname>
            <given-names>Antigoni</given-names>
          </name>
          <xref rid="af1-molbank-2008-M570" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2008-M570" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lafazanis</surname>
            <given-names>Ioannis S.</given-names>
          </name>
          <xref rid="af1-molbank-2008-M570" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harris</surname>
            <given-names>Philip A.</given-names>
          </name>
          <xref rid="af2-molbank-2008-M570" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2008-M570"><label>1</label>Laboratory of Organic Chemistry, Department of Chemical Engineering, College of Engineering, University of Thessaloniki, Thessaloniki 54124, Greece E-mail: <email>kotali@eng.auth.gr</email></aff>
      <aff id="af2-molbank-2008-M570"><label>2</label>GlaxoSmithKline, 1250 South Collegeville Road, P.O.Box 5089, Collegeville, PA 19426-0989, USA E-mail: <email>philip.a.harris@gsk.com</email></aff>
	   <author-notes>
        <corresp id="c1-molbank-2008-M570"><label>*</label>Author to whom correspondence should be addressed.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>08</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>08</month>
        <year>2008</year>
      </pub-date>
      <volume>2008</volume>
      <issue>2</issue>
      <elocation-id>M570</elocation-id>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>04</month>
          <year>2007</year>
        </date>
        <date date-type="rev-recd">
          <day>08</day>
          <month>08</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>08</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>7-hydroxy-8-acetylcoumarin</kwd>
		<kwd>sulfonylhydrazones</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>As part of a research programme targeting novel molecules derived from <italic>o</italic>-hydroxyaryl ketone hydrazones[<xref ref-type="bibr" rid="B1-molbank-2008-M570">1</xref>] we synthesised 7-hydroxy-8-acetylcoumarin phenylsulfonylhydrazone. It is well known than coumarins exhibit a variety of pharmacological properties. Among these properties, their cytotoxic effects have been most extensively investigated [<xref ref-type="bibr" rid="B2-molbank-2008-M570">2</xref>]. Sulfonyl hydrazone derivatives have been also found to possess anticancer properties [<xref ref-type="bibr" rid="B3-molbank-2008-M570">3</xref>]. Thus, the combination of coumarin and sulfonyl hydrazone moieties in one molecule could lead to an interesting anticancer agent.</p>
	  <p><disp-formula>
        <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M570-i001.tif"/>
        </disp-formula></p>
      <p>7-Hydroxy-8-acetylcoumarin was prepared according to the literature method [<xref ref-type="bibr" rid="B4-molbank-2008-M570">4</xref>] whereas, commercially available phenylsulfonyl hydrazide was supplied by Aldrich. Phenylsulfonyl hydrazide (0.42 g, 2.45 mmol) was added to a solution of 7-hydroxy-8-acetylcoumarin (0.5 g, 2.45 mmol) in 1-propanol (15 mL).  The reaction mixture was magnetically stirred at r.t. for 24 hours. The precipitate, which was formed, was initially filtered, then washed with 5mL diethyl ether and finally dried overnight to afford the desired 7-hydroxy-8-acetylcoumarin phenylsulfonylhydrazone as white crystals (1.38 g, 70 %). The product was identified by its <sup>1</sup>H NMR, <sup>13</sup>C NMR and MS without further purification.</p>
      <p>M.p. 196-197 &#xB0;C.</p>
      <p><sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>): 2.02 (s, 3H), 6.20-6.23 (d, 1H, <italic>J</italic>=9.6 Hz), 6.86-6.88 (d, <italic>J</italic>=8.4 Hz, 1H), 7.54-7.64 (m, 4H), 7.66-7.84(m, 2H), 7.93-7.95 (d, <italic>J</italic>=9.6 Hz, 1H), 10.22 (s, 1H), 10.81 (s, 1H).</p>
      <p><sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>): 23.6, 109.6, 111.7, 111.8, 112.6, 127.1, 129.0, 129.8, 132.6, 139.8, 143.4, 147.6, 152.1, 157.4, 160.0.</p>
      <p>MS <italic>m/z</italic> (ESI+) : Calcd. for C<sub>17</sub>H<sub>14</sub>N<sub>2</sub>O<sub>5</sub>S 739.11391 [2M+Na]<sup>+</sup>, 381.05156 [M+Na]<sup>+</sup>. Found: 739.11366 [2M+Na]<sup>+</sup>, 381.05132 [M + Na]<sup>+</sup></p>
  </body>
  <back>
   <app-group>
    <app id="app1-molbank-2008-M570">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2008-M570-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M570-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2008-M570-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M570-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
       </app>
</app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2008-M570">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotali</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>P. A.</given-names>
            </name>
          </person-group>
          <source>Org. Prep. Proc. Int.</source>
          <year>1994</year>
          <volume>26</volume>
		  <issue>2</issue>
          <fpage>155</fpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2008-M570">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kostova</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <source>Curr. Med. Chem.-Anti Cancer Agents</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>29</fpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2008-M570">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cerecetto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Porcal</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
         <source>Mini-Rev. in Med. Cmem.</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>57</fpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2008-M570">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abramov</surname>
              <given-names>M. A.</given-names>
            </name>
            <name>
              <surname>Dehaen</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <source>Synthesis</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>1529</fpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
